LifeMD, Inc. (LFMD) has a 5-year average return on invested capital (ROIC) of -32.1%. This is below average and may indicate limited pricing power.
LifeMD, Inc. (LFMD) has a market capitalization of $176M. It is classified as a small-cap stock.
Yes, LifeMD, Inc. (LFMD) pays a dividend with a trailing twelve-month yield of 1.76%. The company also returns capital through share buybacks, with a buyback yield of 0.15%.
LifeMD, Inc. (LFMD) operates in the Services-Offices & Clinics Of Doctors Of Medicine industry, within the Healthcare sector.
LifeMD, Inc. (LFMD) reported annual revenue of $194 million in its most recent fiscal year, based on SEC EDGAR filings.
LifeMD, Inc. (LFMD) has a net profit margin of 5.8%. This is a modest margin.
LifeMD, Inc. (LFMD) generated $6 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
ITEM 1. BUSINESS We are a direct-to-patient telehealth company providing a high-quality, cost-effective, and convenient way to access comprehensive, virtual and in-home healthcare. We believe the traditional model of visiting a doctor’s office, traveling to a retail pharmacy, and returning for follow-up care or prescription refills is complex, inefficient, and costly which discourages many individuals from seeking much-needed medical care. LifeMD is improving the delivery of the healthcare experience through telehealth with our proprietary technology platform, affiliated and dedicated provider network, broad and expanding treatment capabilities, and the unique ability to nurture patient relationships.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 179M | 194M | 155M | 153M | 119M | 93M |
| Net Income | 990K | 11M | -25M | -24M | -49M | -62M |
| EPS | $0.02 | $0.25 | $-0.60 | $-0.70 | $-1.57 | $-2.29 |
| Free Cash Flow | 3.8M | 6.4M | 16M | 8.6M | -23M | -33M |
| ROIC | -21.6% | 100.1% | -21.2% | -19.6% | -133.7% | -85.9% |
| Gross Margin | 86.0% | 25.8% | 24.6% | 24.3% | 84.3% | 80.6% |
| Debt/Equity | 0.00 | 0.27 | -2.58 | 5.40 | -0.36 | 0.12 |
| Dividends/Share | $0.07 | $0.07 | $0.08 | $0.09 | $0.10 | $0.03 |
| Operating Income | -19M | -7.7M | -20M | -14M | -43M | -54M |
| Operating Margin | -10.7% | -4.0% | -13.2% | -9.5% | -36.5% | -58.5% |
| ROE | 6.6% | 159.8% | - | -676.2% | - | -271.6% |
| Shares Outstanding | 48M | 45M | 41M | 34M | 31M | 27M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 714K | 1.2M | 5.2M | 3.7M | 8.3M | 12M | 37M | 93M | 119M | 153M | 155M | 194M | 179M |
| Gross Margin | 75.8% | 79.7% | 62.9% | 72.4% | 76.0% | 79.7% | 76.2% | 80.6% | 84.3% | 24.3% | 24.6% | 25.8% | 86.0% |
| R&D | N/A | 24K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 316K | 331K | 1.0M | 742K | 2.3M | 2.4M | 45M | 40M | 47M | 52M | 58M | 58M | 12M |
| EBIT | -531K | -262K | -1.2M | -1.2M | -2.1M | -2.9M | -58M | -54M | -43M | -14M | -20M | -7.7M | -19M |
| Op. Margin | -74.3% | -21.5% | -22.4% | -33.4% | -24.7% | -23.2% | -155.0% | -58.5% | -36.5% | -9.5% | -13.2% | -4.0% | -10.7% |
| Net Income | -460K | -62K | -1.1M | -1.2M | -1.2M | -3.1M | -63M | -62M | -49M | -24M | -25M | 11M | 990K |
| Net Margin | -64.5% | -5.1% | -21.1% | -32.8% | -14.9% | -25.2% | -169.9% | -66.5% | -40.9% | -15.5% | -15.8% | 5.8% | 0.6% |
| Non-Recurring | 0 | 127K | 0 | 0 | 595K | 0 | 0 | 57K | 8.0M | 538K | 676K | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | N/M | -76.1% | -117.5% | -86.8% | -137.6% | -66.2% | N/M | -85.9% | -133.7% | -19.6% | -21.2% | 100.1% | -21.6% |
| ROE | N/A | 314.5% | N/A | -457.9% | -139.4% | N/A | N/A | -271.6% | N/A | -676.2% | N/A | 159.8% | 6.6% |
| ROA | -126.7% | -19.9% | -178.9% | -117.4% | -64.0% | -103.5% | -752.1% | -195.1% | -128.7% | -56.3% | -36.4% | 15.4% | 1.4% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 33K | -295K | -408K | -817K | -906K | 251K | -12M | -33M | -23M | 8.8M | 18M | 8.3M | 5.7M |
| Free Cash Flow | 33K | -295K | -408K | -817K | -1.0M | 251K | -12M | -33M | -23M | 8.6M | 16M | 6.4M | 3.8M |
| Owner Earnings | -69K | -416K | -1.7M | -980K | -1.4M | -817K | -31M | -46M | -38M | -4.8M | 4.4M | -3.9M | -7.3M |
| CapEx | 0 | 0 | 0 | 0 | 100K | 0 | 0 | 247K | 367K | 204K | 1.5M | 1.9M | 1.9M |
| Maint. CapEx | 57K | 44K | 679K | 0 | 196K | 336K | 336K | 356K | 1.1M | 1.2M | 842K | 1.7M | 3.5M |
| Growth CapEx | N/A | N/A | N/A | N/A | 0 | N/A | N/A | 0 | 0 | 0 | 621K | 163K | 0 |
| D&A | 57K | 44K | 679K | 0 | 196K | 336K | 336K | 356K | 1.1M | 1.2M | 842K | 1.7M | 3.5M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.3% | 8.5% | N/A | 32.8% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 11K | 0 | 0 | 0 | 0 | 0 | 871K | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.3% | N/A | 2.4% | 1.1% | N/A | 1.8% |
| Share Buybacks | 0 | 0 | 0 | 77K | 0 | 350K | 0 | 0 | 0 | 0 | 0 | 270K | 270K |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | N/A | 0.0% | N/A | 0.0% | N/A | N/A | 0.0% | 0.2% |
| Stock-Based Comp | 45K | 77K | 588K | 163K | 274K | 733K | 19M | 12M | 14M | 12M | 12M | 10M | 9.4M |
| Debt Repayment | 0 | 0 | 0 | 100K | 0 | 284K | 15K | 15M | 0 | 0 | 0 | 19M | 19M |
| Balance Sheet | |||||||||||||
| Net Debt | -21K | 172K | 80K | 236K | 283K | 3K | -7.9M | -39M | 169K | -14M | -12M | -30M | -34M |
| Cash & Equiv. | 75K | 233K | 183K | 141K | 180K | 1.1M | 9.2M | 41M | 4.0M | 33M | 35M | 37M | 34M |
| Long-Term Debt | 27K | 305K | 25K | 167K | 215K | 295K | 242K | 964K | 0 | 18M | 8.4M | N/A | N/A |
| Debt/Equity | -0.39 | 4.05 | -0.74 | 0.43 | 0.52 | -1.12 | -0.57 | 0.12 | -0.36 | 5.40 | -2.58 | 0.27 | 0.00 |
| Interest Coverage | -113.4 | -7.0 | -24.2 | -12.2 | -5.8 | -3.8 | -34.7 | -18.0 | -34.1 | -5.6 | -9.4 | -5.6 | -5.6 |
| Equity | -139K | 100K | -355K | 882K | 898K | -988K | -2.3M | 23M | -11M | 3.5M | -9.1M | 23M | 15M |
| Total Assets | 175K | 448K | 790K | 1.3M | 2.6M | 3.4M | 13M | 50M | 26M | 58M | 76M | 70M | 70M |
| Total Liabilities | 315K | 267K | 1.2M | 641K | 1.8M | 4.6M | 18M | 24M | 38M | 53M | 84M | 47M | 55M |
| Intangibles | N/A | N/A | N/A | N/A | 1.0M | 675K | 340K | 20K | 3.8M | 3.0M | 53K | 262K | 230K |
| Retained Earnings | -8.5M | -8.6M | -9.7M | -11M | -12M | -17M | -80M | -142M | -191M | -214M | -240M | -229M | -238M |
| Working Capital | -170K | 181K | -362K | 623K | 413K | -1.2M | -1.5M | 22M | -20M | 7.8M | -15M | 10M | 2.1M |
| Current Assets | 131K | 448K | 790K | 1.3M | 1.6M | 2.7M | 12M | 45M | 11M | 43M | 52M | 52M | 52M |
| Current Liabilities | 302K | 267K | 1.2M | 641K | 1.2M | 4.0M | 14M | 23M | 31M | 35M | 67M | 42M | 50M |
| Per Share Data | |||||||||||||
| EPS | -0.08 | -0.01 | -0.12 | -0.12 | -0.20 | -1.28 | -4.44 | -2.29 | -1.57 | -0.70 | -0.60 | 0.25 | 0.02 |
| Owner EPS | -0.01 | -0.05 | -0.18 | -0.10 | -0.22 | -0.33 | -2.18 | -1.69 | -1.22 | -0.14 | 0.11 | -0.09 | -0.15 |
| Book Value | -0.02 | 0.01 | -0.04 | 0.09 | 0.14 | -0.40 | -0.16 | 0.84 | -0.37 | 0.10 | -0.22 | 0.51 | 0.32 |
| Cash Flow/Share | 0.01 | -0.04 | -0.04 | -0.08 | -0.15 | 0.10 | -0.85 | -1.23 | -0.74 | 0.26 | 0.43 | 0.18 | 0.10 |
| Dividends/Share | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A | 0.03 | 0.10 | 0.09 | 0.08 | 0.07 | 0.07 |
| Shares Out. | 5.8M | 8.0M | 9.2M | 10.0M | 6.2M | 2.5M | 14.3M | 27.0M | 31.0M | 33.9M | 40.9M | 45.0M | 47.5M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 163.9 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | 6.3 | N/A | N/A | N/A | 32.7 | 13.3 | N/A | 46.4 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 5.6 | N/A | 105.9 | N/A | N/A | 11.7 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | 0.6 | N/A | 3.5 | N/A | 1.1 | 1.4 | N/A | 1.0 |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | 3.6% | N/A | -26.2% | N/A | 2.3% | 6.9% | N/A | 2.2% |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 7.0M | 0 | 127M | 0 | 371M | 233M | 0 | 176M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | 0.00 | 10.62 | 0.00 | 3.85 | 6.89 | 0.00 | 3.71 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.65 | 0.00 | 4.12 | 0.00 | 8.33 | 5.22 | 0.00 | 3.71 |
LifeMD, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 16.0x vs a median of 13.3x. The company's 5-year average gross margin is 47.9%. Total shareholder yield (dividends + buybacks) is 1.9%. At current prices, the estimated annualized return to fair value is +62.5%.
LifeMD, Inc. (LFMD) has a debt-to-equity ratio of 0.27. This indicates a conservatively financed balance sheet.
LifeMD, Inc. (LFMD) reported earnings per share (EPS) of $0.25 in its most recent fiscal year.
LifeMD, Inc. (LFMD) has a return on equity (ROE) of 159.8%. This indicates the company generates strong returns for shareholders.
LifeMD, Inc. (LFMD) has a 5-year average gross margin of 47.9%. This indicates decent pricing power.
The Ledger Terminal provides 14 years of financial data for LifeMD, Inc. (LFMD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
LifeMD, Inc. (LFMD) has a book value per share of $0.51, based on its most recent annual SEC filing.